ArriVent BioPharma, Inc Common Stock

Price & Volume

Track all markets on TradingView

Stats

See more
Open
$27.62
Previous Close
$26.97
Day Range
$27.62-$30.49
52W Range
$16.10-$32.14
Market Cap
$1.2B
Shares Short
7M

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
$0
Diluted EPS
-$3.38

News

See more

Yahoo Finance • 22 days ago

ArriVent Announces IND Clearance for Novel Tetravalent MUC16/NaPi2b Targeting ADC ARR-002 with Initial Focus in Ovarian and Endometrial Cancers

Yahoo Finance • 29 days ago

Noteworthy Thursday Option Activity: AVBP, VIAV, ASTS

Yahoo Finance • 3 months ago

ArriVent Biopharma, Inc. Full Year Loss Increases

Yahoo Finance • 5 months ago

ArriVent Announces First Patient Dosed in Global Pivotal Phase 3 ALPACCA Trial Evaluating Firmonertinib for First-Line Treatment of EGFR PACC Mutant Non-Small Cell Lung Cancer

About

CEO
Dr. Zhengbin Yao Ph.D.
CFO
Mr. Winston Kung M.B.A.
Address
18 Campus Boulevard, Newtown Square, PA, United States, 19073
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
77